Blog
RSS FeedPosted by Michael Wonder on 03 Nov 2021
President Biden announces prescription drug pricing plan in build back better framework
2 November 2021 - Nearly 1 in 4 Americans struggle to afford prescription drugs. ...
Posted by Michael Wonder on 03 Nov 2021
Democrats revive drug pricing reform with a narrow set of proposed measures
2 November 2021 - On Tuesday 2 November, Senator Schumer announced that an agreement had been reached regarding lowering drug ...
Posted by Michael Wonder on 02 Nov 2021
I’ve worked with Robert Califf. He is the leader the FDA needs.
2 November 2021 - If the cascade of news reports are true, President Biden is finally about to name his choice ...
Posted by Michael Wonder on 02 Nov 2021
Democrats reach a breakthrough deal on drug prices, as spending bill nears the finish line
2 November 2021 - Senate Majority Leader Chuck Schumer said Tuesday that Democrats reached an agreement on lowering prescription drug prices. ...
Posted by Michael Wonder on 02 Nov 2021
Delaware to regulate multi-billion dollar pharmacy benefit manager industry, protecting consumers and local businesses
2 November 2021 - Department of Insurance will lead effort to rein in monopolistic behaviour and excessive pharmaceutical costs. ...
Posted by Michael Wonder on 28 Oct 2021
Biden abandons his push to lower drug prices
28 October 2021 - The White House is abandoning every single policy idea aimed at lowering prescription drug prices in ...
Posted by Michael Wonder on 28 Oct 2021
Vulnerable House Democrats warn not to drop drug pricing from package
27 October 2021 - Vulnerable House Democrats are urging leadership not to drop or water down a provision to allow ...
Posted by Michael Wonder on 27 Oct 2021
FDA collaborates with Health Canada and UK’s MHRA to foster good machine learning practice
27 October 2021 - Today, the U.S. FDA, Health Canada and the United Kingdom’s MHRA jointly issued the “Good Machine Learning ...
Posted by Michael Wonder on 27 Oct 2021
FDA, NIH and 15 private organisations join forces to increase effective gene therapies for rare diseases
27 October 2021 - The U.S. FDA, the National Institutes of Health, 10 pharmaceutical companies and five non-profit organisations have partnered ...
Posted by Michael Wonder on 27 Oct 2021
Democratic senators raise concerns with potential FDA pick
26 October 2021 - Sens. Joe Manchin and Richard Blumenthal have concerns with President Biden’s rumoured nominee for the FDA, ...
Posted by Michael Wonder on 26 Oct 2021
Eyenovia announces reclassification of MydCombi as drug device combination product by FDA
25 October 2021 - Company received complete response letter with additional requests and is preparing necessary documents for expedited resubmission, ...
Posted by Michael Wonder on 25 Oct 2021
The risks of government negotiation of drug prices
25 October 2021 - Under the guise of Medicare ‘negotiations,’ the US House of Representatives is considering a measure that would ...
Posted by Michael Wonder on 25 Oct 2021
Drug pricing reform opponents win most pharma lobbying money
26 October 2021 - Democratic Party law makers holding up proposed drug pricing reforms are among the largest beneficiaries of the ...
Posted by Michael Wonder on 25 Oct 2021
Biden speaks with potential FDA commissioner
25 October 2021 - President Joe Biden recently held a call with Dr. Rob Califf, the former FDA commissioner, who ...
Posted by Michael Wonder on 23 Oct 2021
Drug pricing talks heat up as Democrats work to win over skeptics
22 October 2021 - As drug pricing talks in Congress heated up this week, Democrats negotiated in earnest to get ...